1. Home
  2. CYTK vs MIDD Comparison

CYTK vs MIDD Comparison

Compare CYTK & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$75.98

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Middleby Corporation (The)

MIDD

Middleby Corporation (The)

HOLD

Current Price

$141.62

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
MIDD
Founded
1997
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.5B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
CYTK
MIDD
Price
$75.98
$141.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
8
Target Price
$89.26
$180.13
AVG Volume (30 Days)
3.0M
606.7K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
$3,201,202,000.00
Revenue This Year
$7.37
$5.87
Revenue Next Year
$310.19
$3.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.81
$110.82
52 Week High
$80.20
$169.44

Technical Indicators

Market Signals
Indicator
CYTK
MIDD
Relative Strength Index (RSI) 61.72 46.07
Support Level $58.59 $136.35
Resistance Level $80.20 $146.88
Average True Range (ATR) 3.87 5.34
MACD 0.45 -0.56
Stochastic Oscillator 80.49 18.55

Price Performance

Historical Comparison
CYTK
MIDD

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

Share on Social Networks: